These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Biosignature for airway inflammation in a house dust mite-challenged murine model of allergic asthma. Piyadasa H; Altieri A; Basu S; Schwartz J; Halayko AJ; Mookherjee N Biol Open; 2016 Jan; 5(2):112-21. PubMed ID: 26740570 [TBL] [Abstract][Full Text] [Related]
48. Connexin 43 Upregulation in Mouse Lungs during Ovalbumin-Induced Asthma. Yao Y; Zeng QX; Deng XQ; Tang GN; Guo JB; Sun YQ; Ru K; Rizzo AN; Shi JB; Fu QL PLoS One; 2015; 10(12):e0144106. PubMed ID: 26630490 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Lee CC; Lai YT; Chang HT; Liao JW; Shyu WC; Li CY; Wang CN Biochem Pharmacol; 2013 Oct; 86(7):940-9. PubMed ID: 23948063 [TBL] [Abstract][Full Text] [Related]
50. Allergic airway disease is unaffected by the absence of IL-4Rα-dependent alternatively activated macrophages. Nieuwenhuizen NE; Kirstein F; Jayakumar J; Emedi B; Hurdayal R; Horsnell WG; Lopata AL; Brombacher F J Allergy Clin Immunol; 2012 Sep; 130(3):743-750.e8. PubMed ID: 22552110 [TBL] [Abstract][Full Text] [Related]
54. Retraction notice to "Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands" [Bioorg. Med. Chem. 18 (4) (2010) 1434–1440]. Bioorg Med Chem; 2014 Jun; 22(12):3227. PubMed ID: 24955474 [No Abstract] [Full Text] [Related]
55. A new therapeutic target: the CD69-Myl9 system in immune responses. Kimura MY; Koyama-Nasu R; Yagi R; Nakayama T Semin Immunopathol; 2019 May; 41(3):349-358. PubMed ID: 30953160 [TBL] [Abstract][Full Text] [Related]
56. Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease. Yokoyama M; Kimura MY; Ito T; Hayashizaki K; Endo Y; Wang Y; Yagi R; Nakagawa T; Kato N; Matsubara H; Nakayama T Front Immunol; 2020; 11():594297. PubMed ID: 33584659 [TBL] [Abstract][Full Text] [Related]
57. Increased Myosin light chain 9 expression during Kawasaki disease vasculitis. Kobayashi H; Kimura MY; Hasegawa I; Suganuma E; Ikehara Y; Azuma K; Ito T; Ebata R; Kurashima Y; Kawasaki Y; Shiko Y; Saito N; Iwase H; Lee Y; Noval Rivas M; Arditi M; Zuka M; Hamada H; Nakayama T Front Immunol; 2022; 13():1036672. PubMed ID: 36685558 [TBL] [Abstract][Full Text] [Related]
58. Unraveling CD69 signaling pathways, ligands and laterally associated molecules. Jiménez-Fernández M; de la Fuente H; Martín P; Cibrián D; Sánchez-Madrid F EXCLI J; 2023; 22():334-351. PubMed ID: 37223078 [TBL] [Abstract][Full Text] [Related]
59. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma. Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014 [No Abstract] [Full Text] [Related]